Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.

Enomoto N, Oyama Y, Enomoto Y, Yasui H, Karayama M, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.

Chron Respir Dis. 2019 Jan-Dec;16:1479972318809476. doi: 10.1177/1479972318809476. Epub 2018 Oct 31.

2.

Clinical features and outcome of acute exacerbation of interstitial pneumonia associated with connective tissue disease.

Toyoda Y, Hanibuchi M, Kishi J, Kawano H, Morizumi S, Sato S, Kondo M, Takikura T, Tezuka T, Goto H, Nishioka Y.

J Med Invest. 2016;63(3-4):294-9. doi: 10.2152/jmi.63.294.

3.

Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.

Arai T, Kagawa T, Sasaki Y, Sugawara R, Sugimoto C, Tachibana K, Kitaichi M, Akira M, Hayashi S, Inoue Y.

Respirology. 2016 Nov;21(8):1431-1437. doi: 10.1111/resp.12862. Epub 2016 Jul 26.

PMID:
27460223
4.

Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.

Park IN, Kim DS, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Jang SJ, Colby TV.

Chest. 2007 Jul;132(1):214-20. Epub 2007 Mar 30.

PMID:
17400667
5.

Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.

Tachikawa R, Tomii K, Ueda H, Nagata K, Nanjo S, Sakurai A, Otsuka K, Kaji R, Hayashi M, Katakami N, Imai Y.

Respiration. 2012;83(1):20-7. doi: 10.1159/000329893. Epub 2011 Sep 6.

6.

Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.

Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, Imokawa S, Hashizume H, Naito T, Hashimoto D, Takehara Y, Inui N, Nakamura H, Colby TV, Chida K.

Respir Med. 2009 Jun;103(6):846-53. doi: 10.1016/j.rmed.2008.12.019. Epub 2009 Feb 1.

7.

Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.

Enomoto N, Oyama Y, Enomoto Y, Mikamo M, Karayama M, Hozumi H, Suzuki Y, Kono M, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.

Clin Respir J. 2018 Aug;12(8):2378-2389. doi: 10.1111/crj.12918.

PMID:
29873202
8.

CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.

Chung JH, Cox CW, Montner SM, Adegunsoye A, Oldham JM, Husain AN, Vij R, Noth I, Lynch DA, Strek ME.

AJR Am J Roentgenol. 2018 Feb;210(2):307-313. doi: 10.2214/AJR.17.18384. Epub 2017 Nov 15.

PMID:
29140119
9.

Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.

Collins BF, Spiekerman CF, Shaw MA, Ho LA, Hayes J, Spada CA, Stamato CM, Raghu G.

Chest. 2017 Jul;152(1):103-112. doi: 10.1016/j.chest.2017.03.004. Epub 2017 Mar 12.

10.

Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.

Singh P, Thakur B, Mohapatra AK, Padhan P.

Int J Rheum Dis. 2019 Sep;22(9):1741-1745. doi: 10.1111/1756-185X.13666. Epub 2019 Jul 22.

PMID:
31328423
11.
12.

Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.

Abe M, Tsushima K, Matsumura T, Ishiwata T, Ichimura Y, Ikari J, Terada J, Tada Y, Sakao S, Tanabe N, Tatsumi K.

Drug Des Devel Ther. 2015 Oct 23;9:5755-62. doi: 10.2147/DDDT.S90739. eCollection 2015.

13.

Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia.

Moua T, Zamora Martinez AC, Baqir M, Vassallo R, Limper AH, Ryu JH.

Respir Res. 2014 Dec 4;15:154. doi: 10.1186/s12931-014-0154-6.

14.

Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis.

Abe S, Azuma A, Mukae H, Ogura T, Taniguchi H, Bando M, Sugiyama Y.

Intern Med. 2012;51(12):1487-91. Epub 2012 Jun 15.

15.

Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia.

Strand MJ, Sprunger D, Cosgrove GP, Fernandez-Perez ER, Frankel SK, Huie TJ, Olson AL, Solomon J, Brown KK, Swigris JJ.

Chest. 2014 Sep;146(3):775-785. doi: 10.1378/chest.13-2388.

16.
17.

Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases.

Saraya T, Kimura H, Kurai D, Tamura M, Ogawa Y, Mikura S, Sada M, Oda M, Watanabe T, Ohkuma K, Inoue M, Honda K, Watanabe M, Yokoyama T, Fujiwara M, Ishii H, Takizawa H.

Respir Med. 2018 Mar;136:88-92. doi: 10.1016/j.rmed.2018.02.003. Epub 2018 Feb 8.

PMID:
29501253
18.

Comparison of short-term outcomes for connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis after lung transplantation.

Park JE, Kim SY, Song JH, Kim YS, Chang J, Lee JG, Paik HC, Park MS.

J Thorac Dis. 2018 Mar;10(3):1538-1547. doi: 10.21037/jtd.2018.02.50.

19.

Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.

Enomoto N, Oyama Y, Yasui H, Karayama M, Hozumi H, Suzuki Y, Kono M, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.

Sci Rep. 2019 Jul 19;9(1):10484. doi: 10.1038/s41598-019-46990-3.

20.

[The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].

Zhu C, Zhao YB, Kong LF, Li ZH, Kang J.

Zhonghua Jie He He Hu Xi Za Zhi. 2016 Feb;39(2):93-7. doi: 10.3760/cma.j.issn.1001-0939.2016.02.004. Chinese.

PMID:
26879611

Supplemental Content

Support Center